[CIS-PAGID] IVIG reaction
Cunningham-Rundles, Charlotte
charlotte.cunningham-rundles at mssm.edu
Thu Feb 16 09:19:42 EST 2012
So if I really meant to give someone Ig, I would give them say 1- 5 ml SQ in
the office, which would be 1 gram or even less, by slow push. There would
be a place in the low doses given each day or two, that would equal the
whole dose you want. That could also be done at home, each day with a small
amount. (and no pump needed)
Charlotte Cunningham-Rundles, MD, PhD
Departments of Medicine and Pediatrics
The David S Gottesman Professor
The Immunology Institute
Mount Sinai School of Medicine
1425 Madison Avenue
New York, NY 10029
Phone: 212 659 9268
Fax: 212 987 5593
Email: Charlotte.Cunningham-Rundles at mssm.edu
> From: "Hare, Nathaniel D" <NHare at Cheshire-Med.COM>
> Reply-To: PAGID <pagid at list.clinimmsoc.org>
> Date: Wed, 15 Feb 2012 18:32:15 -0500
> To: PAGID <pagid at list.clinimmsoc.org>
> Subject: Re: [CIS-PAGID] IVIG reaction
>
> And yes, both episodes of aseptic meningitis were documented by lumbar
> puncture.
>
> Nathaniel D. Hare MD
> Allergy & Immunology
> CMC - Dartmouth Hitchcock Keene
> Keene, NH 03431
>
> ph (603) 354-5496
> fax (603) 354-5498
> -----Original Message-----
> From: pagid-bounces at list.clinimmsoc.org
> [mailto:pagid-bounces at list.clinimmsoc.org] On Behalf Of Hare, Nathaniel D
> Sent: Wednesday, February 15, 2012 6:21 PM
> To: pagid at list.clinimmsoc.org
> Subject: Re: [CIS-PAGID] IVIG reaction
>
> As a follow up question though - I have 1 patient with recurrent pneumonia
> (documented), specific antibody deficiency, IgG in the 500's, otherwise normal
> immune evaluation, who has had aseptic meningitis with both IVIG and subQ IgG
> treatment.
>
> Assuming you have a patient with an appropriate diagnosis of immune deficiency
> that is antibody based, who has severe documented infections, who needs IgG
> replacement therapy, what do you do if they have aseptic meningitis with both
> IV and SubQ IgG replacement?
>
> I realize you may argue with me about my specific patient's need for IgG
> therapy, but if you could address the question about what to do with aseptic
> meningitis with both product formulations, that would be great.
>
> Thanks,
>
> Nathan Hare
>
>
>
> Nathaniel D. Hare MD
> Allergy & Immunology
> CMC - Dartmouth Hitchcock Keene
> Keene, NH 03431
>
> ph (603) 354-5496
> fax (603) 354-5498
> -----Original Message-----
> From: pagid-bounces at list.clinimmsoc.org
> [mailto:pagid-bounces at list.clinimmsoc.org] On Behalf Of Nelson, Robert P Jr
> Sent: Wednesday, February 15, 2012 4:31 PM
> To: 'pagid at list.clinimmsoc.org'
> Subject: Re: [CIS-PAGID] IVIG reaction
>
> Agree with Jack and Charlotte, multiple anecdotes. Bob
>
> Robert P. Nelson Jr., MD
> Professor of Medicine and Pediatrics
> Divisions of Hematology/Oncology
> 535 Barnhill Dr. Ste 473
> Indianapolis, IN 46202
> Telephone: 317-948-1186
> E-mail: ronelson at iupui.edu
> pager: 317-312-1773
>
>
> -----Original Message-----
> From: pagid-bounces at list.clinimmsoc.org
> [mailto:pagid-bounces at list.clinimmsoc.org] On Behalf Of Cunningham-Rundles,
> Charlotte
> Sent: Wednesday, February 15, 2012 3:58 PM
> To: PAGID
> Subject: Re: [CIS-PAGID] IVIG reaction
>
> I agree with Jack. In my experience, the ones that have the most trouble with
> bad reactions over time, are the most likely to not need it....
>
> I have not collected data on this very rigorously but sure have seen this a
> lot --aseptic meningitis, admissions to ER etc/.... You may have to persuade
> her to have a better workup first.
>
>
> Charlotte
>
> Charlotte Cunningham-Rundles, MD, PhD
> Departments of Medicine and Pediatrics
> The Immunology Institute
> Mount Sinai School of Medicine
> 1425 Madison Avenue
> New York, NY 10029
> Phone: 212 659 9268
> Fax: 212 987 5593
> Email: Charlotte.Cunningham-Rundles at mssm.edu
>
>
>
>
>> From: Jack R <jroutes at mcw.edu>
>> Reply-To: PAGID <pagid at list.clinimmsoc.org>
>> Date: Wed, 15 Feb 2012 14:48:44 -0600
>> To: PAGID <pagid at list.clinimmsoc.org>
>> Subject: Re: [CIS-PAGID] IVIG reaction
>>
>> HI Niraj
>> I am not convinced that she needs Ab replacement. Was there documented
>> sinus disease prior to the initiation of IVIG or just symptoms
>> compatable with sinusitis? Did she have an abnormal specific Ab
>> response to pneumovax? Was she tried on more conservative measures
>> (nasal washes, intranasal steroids) prior to IVIG?
>>
>> I frequently see patients with symptoms suggestive of
>> recurrent/chronic sinusitis, but no or little abnormalities when I obtain a
>> CT scan.
>> Furthermore, most patients will have a reduction in URIs with IVIG,
>> regardless of whether they have an immune deficiency.
>>
>> If you are convinced she has specific Ab deficiency and needs
>> replacement therapy, I agree with Elie and would use subcut.
>>
>> good luck
>>
>> Jack
>>
>>
>> John M. Routes, MD
>> Chief, Section of Allergy and Clinical Immunology Professor of
>> Pediatrics, Medicine, Microbiology and Molecular Genetics Department
>> of Pediatrics Children's Hospital of Wisconsin Medical College of
>> Wisconsin
>>
>> ________________________________
>> From: pagid-bounces at list.clinimmsoc.org
>> [pagid-bounces at list.clinimmsoc.org] On Behalf Of Patel, Niraj C
>> [Niraj.Patel at carolinashealthcare.org]
>> Sent: Wednesday, February 15, 2012 2:22 PM
>> To: 'pagid at list.clinimmsoc.org'
>> Subject: [CIS-PAGID] IVIG reaction
>>
>> Dear Colleagues,
>>
>> I saw this patient for the first time this week, and she has extreme
>> difficulty tolerating IVIG infusions.
>> 45 yo female with lupus since 1994, history of pericarditis,
>> antiphospholipid syndrome, oral ulcers and peripheral neuropathy. She
>> received epratuzumab
>> (antiCD22) for lupus in June 2008 (IgG level prior was 610). She was
>> started on IVIG in March 2009 for low IgG 530 (normal IgA, IgM) and
>> chronic sinusitis despite. No antibody to vaccines was done. She
>> initially tolerated IVIG
>> (400mg/kg) for several months (IgG levels in 700-800), until she began
>> developing headaches, vomiting, fever. No laryngeal swelling,
>> wheezing, or hives. Despite premedication with 50mg Benadryl,
>> changing IVIG formulations, 20mg demamethasone the night prior and
>> 20mg the morning of infusion, decadron (unknown dose) prior to
>> infusion, and rate slowed to 70cc/hr (15 hour-long infusion), her
>> symptoms worsened. She had aseptic meningitis in May 2011 and Nov 30
>> 2011 thought due to IVIG, although the latter episode occurred 6 days
>> after infusion and no lumbar puncture done either time. Symptoms
>> included fever, neck pain, vomiting, photophobia and was hospitalized for 1
>> week each time and treated with high-dose steroids.
>>
>> During the almost 2 years on IVIG, she noted remarkable improvement in
>> sinus symptoms and had just 1 sinusitis during this time period
>> (compared to chronic nasal symptoms and antibiotics at least once
>> monthly prior to IVIG). She stopped her IVIG after Nov 30 2011 due to
>> adverse reaction and her chronic nasal symptoms returned after 4-6
>> weeks. CT of sinus this week was negative except scant sphenoid fluid
>> and endoscopy of nasal passages was normal (she was on levoquin at that
>> time). Most recent labs on 1/26/12:
>>
>> IgG 563 (791-1643)
>> IgA 89 (66-436)
>> IgM 75 (43-279)
>> WBC 9,100
>> ALC 1,065
>> CD19B 53 (90-660)
>> CD3T 809 (690-2,540)
>> CD4T 405 (410-1,590)
>> CD8T 362 (195-1,140)
>> CD56/16 181 (90-590)
>>
>> 1) Would you restart Ig replacement? Try subQ in a monitored setting?
>> 2) Hold on Ig replacement therapy until more definitive evidence of a
>> chronic infectious process?
>> 3) Could an autoantibody to Ig be present in this setting? If so,
>> offer rituximab?
>>
>> Thank you in advance for your help.
>>
>> Niraj
>>
>> Niraj Patel, MD MS
>>
>> Department of Pediatrics
>> Infectious Diseases and Immunology
>> Levine Children's Hospital
>> Carolinas Medical Center
>> PO Box 32861
>> Charlotte, NC 28232-2861
>>
>> Tel: (704) 381-6803
>> Fax: (704) 381-6841
>> Appt: (704) 381-8840
>>
>> Email:
>>
>
niraj.patel at carolinashealthcare.org<mailto:niraj.patel at carolinashealthcare.org>
>
>>
>>
>>
>> ________________________________
>>
>> This electronic message may contain information that is confidential
>> and/or legally privileged. It is intended only for the use of the
>> individual(s) and entity named as recipients in the message. If you
>> are not an intended recipient of this message, please notify the
>> sender immediately and delete the material from any computer. Do not
>> deliver, distribute or copy this message, and do not disclose its
>> contents or take any action in reliance on the information it contains. Thank
>> you.
>
More information about the PAGID
mailing list